Literature DB >> 1437498

Clearance of indomethacin occurs predominantly by renal glucuronidation.

F Moolenaar1, S Crancrinus, J Visser, D De Zeeuw, D K Meijer.   

Abstract

In this report we describe the conditions of collection, storage and handling of urine samples, collected after oral dosing with indomethacin in man, in order to maintain the integrity of the labile glucuronide formed. We found that the body clearance occurs predominantly by renal metabolism, due to glucuronidation in the human kidney. These glucuronides may be converted to isomeric glucuronides and/or the parent compound indomethacin during the residence time in the bladder.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1437498     DOI: 10.1007/bf01962537

Source DB:  PubMed          Journal:  Pharm Weekbl Sci        ISSN: 0167-6555


  14 in total

1.  Kinetics of indomethacin absorption, elimination, and enterohepatic circulation in man.

Authors:  K C Kwan; G O Breault; E R Umbenhauer; F G McMahon; D E Duggan
Journal:  J Pharmacokinet Biopharm       Date:  1976-06

Review 2.  Pharmacokinetic drug interactions with nonsteroidal anti-inflammatory drugs.

Authors:  R K Verbeeck
Journal:  Clin Pharmacokinet       Date:  1990-07       Impact factor: 6.447

3.  The metabolism of indomethacin in man.

Authors:  D E Duggan; A F Hogans; K C Kwan; F G McMahon
Journal:  J Pharmacol Exp Ther       Date:  1972-06       Impact factor: 4.030

Review 4.  The pharmacokinetics of non-steroidal anti-inflammatory drugs in the elderly.

Authors:  K W Woodhouse; H Wynne
Journal:  Clin Pharmacokinet       Date:  1987-02       Impact factor: 6.447

Review 5.  Properties of acyl glucuronides: implications for studies of the pharmacokinetics and metabolism of acidic drugs.

Authors:  E M Faed
Journal:  Drug Metab Rev       Date:  1984       Impact factor: 4.518

6.  Apparent intramolecular acyl migration of zomepirac glucuronide.

Authors:  J Hasegawa; P C Smith; L Z Benet
Journal:  Drug Metab Dispos       Date:  1982 Sep-Oct       Impact factor: 3.922

7.  The formation of beta-glucuronidase resistant glucuronides by the intramolecular rearrangement of glucuronic acid conjugates at mild alkaline pH.

Authors:  K A Sinclair; J Caldwell
Journal:  Biochem Pharmacol       Date:  1982-03-15       Impact factor: 5.858

8.  The interaction between indomethacin and probenecid. A clinical and pharmacokinetic study.

Authors:  N Baber; L Halliday; R Sibeon; T Littler; M L Orme
Journal:  Clin Pharmacol Ther       Date:  1978-09       Impact factor: 6.875

9.  Biliary elimination of indomethacin in man.

Authors:  B Terhaag; U Hermann
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

10.  Pharmacokinetics, N1-glucuronidation and N4-acetylation of sulfamethomidine in humans.

Authors:  T B Vree; E W Beneken Kolmer; Y A Hekster
Journal:  Pharm Weekbl Sci       Date:  1991-10-18
View more
  3 in total

1.  Effect of indomethacin on bile acid-phospholipid interactions: implication for small intestinal injury induced by nonsteroidal anti-inflammatory drugs.

Authors:  Yong Zhou; Elizabeth J Dial; Rand Doyen; Lenard M Lichtenberger
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-03-04       Impact factor: 4.052

2.  Probenecid inhibits the glucuronidation of indomethacin and O-desmethylindomethacin in humans. A pilot experiment.

Authors:  T B Vree; M van den Biggelaar-Martea; C P Verwey-van Wissen; E W van Ewijk-Beneken Kolmer
Journal:  Pharm World Sci       Date:  1994-02-18

3.  Low molecular weight proteins as carriers for renal drug targeting: naproxen coupled to lysozyme via the spacer L-lactic acid.

Authors:  E J Franssen; F Moolenaar; D de Zeeuw; D K Meijer
Journal:  Pharm Res       Date:  1993-07       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.